Poland· PL-100463634

CitraFleet

A natrium-picosulfat, kombinationen product containing natrii picosulfas + magnesii oxidum leve + acidum citricum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC A06AB58

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCitraFleetATCA06AB58REGISTER NO.PL-100463634PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Natrium-picosulfat, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC A06AB58 (natrium-picosulfat, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Natrium-picosulfat, kombinationen · ATC A06AB58

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Natrii picosulfas + Magnesii oxidum leve + Acidum citricum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
A06AB58
ATC class
Natrium-picosulfat, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991474737
  • gtin
    05909991474744
  • gtin
    05909991474751

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Natrium-picosulfat, kombinationen in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All natrium-picosulfat, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f18b5864-ba12-4549-a4ce-edcef56f4c06
GET /v1/drugs/f18b5864-ba12-4549-a4ce-edcef56f4c06?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania roztworu doustnego",
  "source": "urpl",
  "strength": "(0,01 g + 3,50 g + 10,97 g)/saszetkę",
  "packaging": "05909991474737 ¦ Rp ¦ 143532\n50 sasz. \n05909991474744 ¦ Rp ¦ 143533\n2 sasz. \n05909991474751 ¦ Rp ¦ 143534\n100 sasz.",
  "substance": "Natrii picosulfas 0,01 g/saszetkę + Magnesii oxidum leve 3,50 g/saszetkę + Acidum citricum 10,97 g/saszetkę",
  "common_name": "Natrii picosulfas + Magnesii oxidum leve + Acidum citricum",
  "pl_product_id": "100463634",
  "pozwolenie_nr": "44/22",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-01-20"
}

See everything about natrium-picosulfat, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.